EUVIMEDEUVIMED entdecken
Open Access

Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents

Papireddy Kancharla iD, Diana Ortiz, Corinne M Fargo iD, Xiaowei Zhang, Yuexin Li, Marco Sanchez, Amrendra Kumar, Monish Yeluguri, Rozalia A Dodean iD, Diana Caridha, Michael S Madejczyk, Monica Martin und 18 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Papireddy Kancharla und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Portland State University, Portland, Oregon 97201, United States. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Leishmania donovani, Leishmania mexicana. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis is a neglected tropical disease that is estimated to afflict over 12 million people. Current drugs for leishmaniasis suffer from serious deficiencies, including toxicity, high cost, modest efficacy, primarily parenteral delivery, and emergence of widespread resistance. We have discovered and developed a natural product-inspired tambjamine chemotype, known to be effective against Plasmodium spp, as a novel class of antileishmanial agents. Herein, we report in vitro and in vivo antileishmanial activities, detailed structure-activity relationships, and metabolic/pharmacokinetic profiles of a large library of tambjamines. A number of tambjamines exhibited excellent potency against both Leishmania mexicana and Leishmania donovani parasites with good safety and metabolic profiles. Notably, tambjamine 110 offered excellent potency and provided partial protection to leishmania-infected mice at 40 and/or 60 mg/kg/10 days of oral treatment. This study presents the first account of antileishmanial activity in the tambjamine family and paves the way for the generation of new oral antileishmanial drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsLeishmania donovaniLeishmania mexicanaAnimalsStructure-Activity RelationshipMiceDrug DiscoveryHumansFemaleLeishmaniasisMice, Inbred BALB C

Substanzen

Antiprotozoal Agents

Autor:innen und Institutionen

  • Department of Chemistry, Portland State University, Portland, Oregon 97201, United States.
  • Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon 97239, United States.
  • Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States.
  • Experimental Therapeutics Branch, CIDR, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States.

ORCID-Profile: Papireddy Kancharla, Corinne M Fargo, Rozalia A Dodean, Kevin A Reynolds, Jane X Kelly, Scott M Landfear

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Kancharla, P., Ortiz, D., Fargo, C. M., Zhang, X., Li, Y., Sanchez, M., Kumar, A., Yeluguri, M., Dodean, R. A., Caridha, D., Madejczyk, M. S., Martin, M., Jin, X., Blount, C., Chetree, R., Pannone, K., Dinh, H. T., DeLuca, J., Evans, M., …, & Landfear, S. M. (2024). Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00517

Vancouver

Kancharla P, Ortiz D, Fargo CM, Zhang X, Li Y, Sanchez M, et al. Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00517

BibTeX
@article{Kancharla2024,
  author = {Kancharla, Papireddy and Ortiz, Diana and Fargo, Corinne M and Zhang, Xiaowei and Li, Yuexin and Sanchez, Marco and Kumar, Amrendra and Yeluguri, Monish and Dodean, Rozalia A and Caridha, Diana and Madejczyk, Michael S and Martin, Monica and Jin, Xiannu and Blount, Cameron and Chetree, Ravi and Pannone, Kristina and Dinh, Hieu T and DeLuca, Jesse and Evans, Martin and Nadeau, Robert and Vuong, Chau and Leed, Susan and Dennis, William E and Roncal, Norma and Pybus, Brandon S and Lee, Patricia J and Roth, Alison and Reynolds, Kevin A and Kelly, Jane X and Landfear, Scott M},
  title = {Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00517}
}
Kostenlos starten →